Tuberculosis-related knowledge, practices, perceived stigma and discrimination, and adherence to anti-TB medication among patients with tuberculosis: A cross-sectional study in Jordan (Preprint)
Rana AlHamawi, Yousef Khader, Hiba Abaza, Srinath Satyanarayana, Nevin Wilson, Ahmad Saleh Abu Rumman, Khaled Okkah
Abstract
<sec> <title>BACKGROUND</title> Tuberculosis knowledge, practices, adherence to treatment among patients with tuberculosis are key factors for the management of the disease. </sec> <sec> <title>OBJECTIVE</title> The objectives of the study were to assess knowledge, practices, perceived stigma and discrimination, perceived family and health workers support, perceived level of satisfaction with healthcare services, delay in diagnosis/treatment and reasons for delay, and adherence to tuberculosis medication among patients with tuberculosis in Jordan. </sec> <sec> <title>METHODS</title> A cross-sectional study was conducted among patients who were under treatment for tuberculosis in Jordan in 2021. A structured questionnaire was developed, pilot tested and used for data collection. </sec> <sec> <title>RESULTS</title> This study included a total of 452 patients with tuberculosis. About 91.4% (413/452) of patients had low to moderate overall tuberculosis-related knowledge score and 8.6% had high knowledge score. Almost two-thirds of patients (67.5%, n = 305/452) had perceived a low level of stigma, 61 (13.5%) perceived a moderate level of stigma, and 86 (19.0%) perceived a high level of stigma. About 43.6% (197/ 452) of patients with tuberculosis felt stigmatized due to their tuberculosis status. Of those, almost 64.0% (126/197) reported that such feelings inhibited them from seeking healthcare services. A total of 156 out of 452 (34.5%) patients experienced a high level of discrimination, 33 (7.3%) experienced a moderate level of discrimination, and 263 (58.2%) experienced a low level of discrimination. The majority (84.5%, 382/452) of patients with tuberculosis thought that there was a delay in diagnosis and/or treatment of TB. Overall, 36.9% (167/452) of patients were not adherent to TB medication. </sec> <sec> <title>CONCLUSIONS</title> Our study showed gaps in tuberculosis knowledge and practices, high perceived stigma and discrimination, perceived delay in diagnosis and treatment initiation, non-adherence to anti- TB medications, and difficulties in accessing TB services during COVID-19 pandemic. Efforts within the national TB control program should be made to increase public awareness about the symptoms of tuberculosis and the importance of seeking early care. </sec> <sec> <title>CLINICALTRIAL</title> <p/> </sec>
MeSH terms
- Tuberculosis
- Medicine
- Stigma (botany)
- Cross-sectional study
- Feeling
- Family medicine
- Social stigma
- Disease